220 related articles for article (PubMed ID: 33406501)
1. Prognostic and clinical significance of modified glasgow prognostic score in pancreatic cancer: a meta-analysis of 4,629 patients.
Wu D; Wang X; Shi G; Sun H; Ge G
Aging (Albany NY); 2021 Jan; 13(1):1410-1421. PubMed ID: 33406501
[TBL] [Abstract][Full Text] [Related]
2. A high Glasgow prognostic score (GPS) or modified Glasgow prognostic score (mGPS) predicts poor prognosis in gynecologic cancers: a systematic review and meta-analysis.
Nie D; Zhang L; Wang C; Guo Q; Mao X
Arch Gynecol Obstet; 2020 Jun; 301(6):1543-1551. PubMed ID: 32409927
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Significance of the Modified Glasgow Prognostic Score in Patients With Pancreatic Cancer: A Meta-Analysis.
Fu W; Wang K; Yan S; Wang X; Tang B; Chang J; Wang R; Wu T
Dose Response; 2020; 18(3):1559325820942065. PubMed ID: 32821253
[TBL] [Abstract][Full Text] [Related]
4. The prognostic value of modified Glasgow Prognostic Score in pancreatic cancer: a meta-analysis.
Zhang H; Ren D; Jin X; Wu H
Cancer Cell Int; 2020; 20():462. PubMed ID: 32982584
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value of modified Glasgow prognostic score in patients with esophageal squamous cell cancer: a Meta-analysis.
Wang Y; Chen L; Wu Y; Li P; Che G
Nutr Cancer; 2020; 72(7):1146-1154. PubMed ID: 31617767
[No Abstract] [Full Text] [Related]
6. Prognostic Value of the Glasgow Prognostic Score or Modified Glasgow Prognostic Score for Patients with Colorectal Cancer Receiving Various Treatments: a Systematic Review and Meta-Analysis.
He L; Li H; Cai J; Chen L; Yao J; Zhang Y; Xu W; Geng L; Yang M; Chen P; Zheng J; Yang Y; Gong S
Cell Physiol Biochem; 2018; 51(3):1237-1249. PubMed ID: 30481755
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Modified Glasgow Prognostic Score for Pancreatic Cancer: A Retrospective Cohort Study.
Imaoka H; Mizuno N; Hara K; Hijioka S; Tajika M; Tanaka T; Ishihara M; Yogi T; Tsutsumi H; Fujiyoshi T; Sato T; Shimizu Y; Niwa Y; Yamao K
Pancreas; 2016 Feb; 45(2):211-7. PubMed ID: 26495775
[TBL] [Abstract][Full Text] [Related]
8. Clinical utility of the modified Glasgow prognostic score in lung cancer: A meta-analysis.
Jin J; Hu K; Zhou Y; Li W
PLoS One; 2017; 12(9):e0184412. PubMed ID: 28886134
[TBL] [Abstract][Full Text] [Related]
9. Pre-treatment Glasgow prognostic score and modified Glasgow prognostic score may be potential prognostic biomarkers in urological cancers: a systematic review and meta-analysis.
Qi F; Xu Y; Zheng Y; Li X; Gao Y
Ann Transl Med; 2019 Oct; 7(20):531. PubMed ID: 31807513
[TBL] [Abstract][Full Text] [Related]
10. The preoperative sensitive-modified Glasgow prognostic score is superior to the modified Glasgow prognostic score in predicting long-term survival for esophageal squamous cell carcinoma.
Tian R; Zhang F; Sun P; Wu J; Yan H; Wu AR; Zhang M; Jiang YL; Lu YH; Xu QY; Zhan XH; Zhang RX; Qian LT; He J
Oncotarget; 2016 Oct; 7(41):67485-67494. PubMed ID: 27528228
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Utility of the Modified Glasgow Prognostic Score in Urothelial Carcinoma: Outcomes from a Pooled Analysis.
Tan D; Li J; Lin T; Tan P; Zhang J; Xiong Q; Jiang J; Li Y; Zhang P; Wei Q
J Clin Med; 2022 Oct; 11(21):. PubMed ID: 36362488
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Value of Pretreatment Glasgow Prognostic Score/Modified Glasgow Prognostic Score in Ovarian Cancer: A Systematic Review and Meta-Analysis.
Xu S; Song L; Liu X
Nutr Cancer; 2022; 74(6):1968-1975. PubMed ID: 34549675
[TBL] [Abstract][Full Text] [Related]
13. A comprehensive analysis of Glasgow Prognostic Score (GPS)/the modified Glasgow Prognostic Score (mGPS) on immune checkpoint inhibitor efficacy among patients with advanced cancer.
Zhang Y; Chen S; Chen H; Li W
Cancer Med; 2023 Jan; 12(1):38-48. PubMed ID: 35702873
[TBL] [Abstract][Full Text] [Related]
14. A Meta-Analysis of Glasgow Prognostic Score and Modified Glasgow Prognostic Score as Biomarkers for Predicting Survival Outcome in Renal Cell Carcinoma.
Tong T; Guan Y; Xiong H; Wang L; Pang J
Front Oncol; 2020; 10():1541. PubMed ID: 33042799
[No Abstract] [Full Text] [Related]
15. Modified Glasgow prognostic score might be a prognostic factor for hepatocellular carcinoma: a meta-analysis.
Chen H; Hu N; Chang P; Kang T; Han S; Lu Y; Li M
Panminerva Med; 2017 Dec; 59(4):302-307. PubMed ID: 28001023
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort.
Jansson H; Cornillet M; Björkström NK; Sturesson C; Sparrelid E
Eur J Surg Oncol; 2020 May; 46(5):804-810. PubMed ID: 31848078
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the Glasgow Prognostic Score (GPS) and the modified Glasgow Prognostic Score (mGPS) in evaluating the prognosis of patients with operable and inoperable non-small cell lung cancer.
Fan H; Shao ZY; Xiao YY; Xie ZH; Chen W; Xie H; Qin GY; Zhao NQ
J Cancer Res Clin Oncol; 2016 Jun; 142(6):1285-97. PubMed ID: 26864695
[TBL] [Abstract][Full Text] [Related]
18. The glasgow prognostic score as a predictor of survival in patients with potentially resectable pancreatic adenocarcinoma.
La Torre M; Nigri G; Cavallini M; Mercantini P; Ziparo V; Ramacciato G
Ann Surg Oncol; 2012 Sep; 19(9):2917-23. PubMed ID: 22488099
[TBL] [Abstract][Full Text] [Related]
19. Association between preoperative C-reactive protein level and colorectal cancer survival: a meta-analysis.
Woo HD; Kim K; Kim J
Cancer Causes Control; 2015 Nov; 26(11):1661-70. PubMed ID: 26376895
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of the Glasgow prognostic score in colorectal cancer: a meta-analysis of 9,839 patients.
Lu X; Guo W; Xu W; Zhang X; Shi Z; Zheng L; Zhao W
Cancer Manag Res; 2019; 11():229-249. PubMed ID: 30636896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
